After price cap, local stent makers capture 60% of market

Price regulation has also allowed better margins to Indian companies even as locally made, lower-priced products gain in the market, helping local players increase revenues. The share of Indian companies in terms of value has increased from 30% in 2016-17 to over 55% in 2019-20.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/35JC8GV
via IFTTT